EENet Logo


Best practice recommendations for Canadian harm reduction programs that provide service to people who use drugs and are at risk for HIV, HCV, and other harms – part 1 (2013)

Drug use practices that can lead to transmission of immunodeficiency virus (HIV) and other harms (such as reusing and sharing injection and smoking equipment) are a critical public health issue that affects communities across Ontario and Canada.

Evidence shows that effective prevention programs for people who use drugs can reduce transmission of HIV and hepatitis B (HBV), and other harms related to drug use. Harm reduction programs, like needle and syringe programs, lead to fewer people having HIV and less needle and equipment reuse, and are cost effective.

This report presents part 1 of best practice recommendations to improve the effectiveness of harm reduction programs that deliver prevention services to people who use drugs and are at risk of HIV, HBV, and hepatitis C, and other harms. 

EENet has developed a Research Report Round-up of the report, “Best Practice Recommendations for Canadian Harm Reduction Programs that Provide Service to People Who Use Drugs and Are at Risk for HIV, HCV, and Other Harms – Part 1.”

Research Report Round-ups are brief summaries of research reports, presented in a user-friendly format.

Full Version: Download PDF Icon

Categories: Harm Reduction , Health Systems and Services , Prevention / Health Promotion , Treatment, Supports, and Services